Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Alzheimer’s Disease Market Infographic

  • Home Blog Alzheimers disease market infographic

Alzheimer’s Disease Market Infographic

Nov 29, 2019

Alzheimer's Disease Market Infographic
Alzheimer’s Disease Market Infographic

It’s is the end of Alzheimer’s Awareness Month, but our hope for a cure for this disease will not end.

They may not remember us, but we need to remember that Alzheimer’s battle is not theirs alone, but all of ours.

Downloads

Article in PDF

Recent Articles
  1. FDA rejects BioMarin’s Valoctocogene Roxaparvovec; J&J inks $6.5B deal; Alzheon bags $...
  2. Alzheimer’s drug fails! Is it time to move on?
  3. Amylyx Raises $30M; QurAlis Announces License Agreement Deal With Lilly; COVID-19 Vaccine Updates...
  4. Tepezza receives approval; a new way to treat Alzheimer’s
  5. Amgen’s IMDELLTRA FDA Approval; J&J’s Proteologix Acquisition; Bristol Myers Squibb’s B...
kinsunla-for-alzheimer-disease-treatment
Articles

A New Dawn in Alzheimer’s Disease Treatment: Eli Lilly’s Donanemab Wins FDA Approval

pharma-news-for-amgen-bms-abbvie-eisai
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Amgen’s IMDELLTRA FDA Approval; J&J’s Proteologix Acquisition; Bristol Myers Squibb’s BREYANZI FDA Approval; AbbVie and Gilgamesh Pharmaceuticals’ Agreement; Eisai’s LEQEMBI FDA Fast Track Status

pharma-news-for-takeda-ac-immune-eli-lilly-bristol-myers-squibb
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Takeda and AC Immune’s Alzheimer’s Deal; Eli Lilly’s Donanemab FDA Review; Bristol Myers Squibb’s Phase III CheckMate -73L Trial Result; Regeneron Pharmaceuticals’ Dupixent sBLA; Excision BioTherapeutics’ EBT-101 Phase I/II Trial Results

Alzheimer's Disease Market
Alzheimer's Disease Market Infographic
Alzheimer’s Disease
loader